Vicore announces participation in investor meetings during June 2021
Gothenburg, June 15, 2021 - Vicore Pharma Holding AB (publ) (“Vicore”), a rare disease pharmaceutical company developing innovative medicines for fibrotic lung disorders such as idiopathic pulmonary fibrosis (IPF), today announces the participation in two upcoming investor meetings in June 2021.Date: Wednesday, 23 June, 2021Presentation: 16:40 CET (10:40 AM EDT)Event and registration: NewYorkBIO/NYSE Emerging Biotech Company Showcase CEO Carl-Johan Dalsgaard will present an overview of the company’s